What kind of medicine is Lynparza? What's the price?

Olaparib is an innovative targeted drug that is different from traditional chemotherapy drugs and specifically acts on cancer cells carrying specific gene mutations.

As the first oral polyADP ribose polymerase (PARP) inhibitor, olaparib can effectively kill cancer cells or inhibit their growth by inhibiting the function of DNA damage repair enzyme (PARP). This mechanism makes olaparib highly effective in the treatment of advanced epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer carrying BRCA gene mutations. At the same time, olaparib has also shown potential in the treatment of other cancers such as pancreatic cancer.

Compared with chemotherapy drugs, olaparib is more targeted and can reduce damage to normal cells, thereby reducing side effects during treatment and improving patients' quality of life and prognosis. At present, Lynparza has been marketed in the country and has been included in my country's medical insurance reimbursement items. The original version of olaparib tablets on the domestic market is 150mg*56 tablets, and the price after medical insurance reimbursement is about 4,500 yuan. It is recommended to consult the local hospital for specific prices. It is understood that there are multiple generic versions of olaparib available overseas, available in capsules and tablets. The specifications of the generic version of olaparib capsules listed overseas are 50mg * 112 capsules, and the price ranges from 1,600 to 1,800 yuan; the specification of the generic version of olaparib tablets listed overseas is 150mg * 120 capsules, and the price ranges from 2,000 to 5,700 yuan.

Overall, olaparib is an epoch-making targeted drug that brings new treatment hope to many cancer patients. If patients have more questions about Lynparza, please consult a professional doctor.